The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Surveillance of resected metastatic colorectal cancer utilizing circulating DNA.
 
Nikolas Naleid
No Relationships to Disclose
 
Kevin Zablonski
No Relationships to Disclose
 
Hanna Kakish
No Relationships to Disclose
 
Melissa Amy Lumish
No Relationships to Disclose
 
David L Bajor
Employment - University Hospitals Case Medical Center
Stock and Other Ownership Interests - Mirati Therapeutics
Consulting or Advisory Role - Guidepoint Global
Speakers' Bureau - Natera
Research Funding - Abbvie; Apexigen (Inst); Bristol-Myers Squibb/Celgene (Inst); Calithera Biosciences (Inst); GlaxoSmithKline (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst); Tesaro (Inst)
 
J. Eva Selfridge
Research Funding - Arcus Biosciences (Inst); BioAtla (Inst); CUE Biopharma (Inst); Tizona Therapeutics, Inc. (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - Arcus Biosciences; DAVA Pharmaceuticals
 
Madison Conces
No Relationships to Disclose
 
AMR MOHAMED
Honoraria - Ipsen; Triple A
Consulting or Advisory Role - Triple A
Speakers' Bureau - Ipsen
Research Funding - Novatek Pharmaceuticals
 
Sakti Chakrabarti
Honoraria - BioMedical Insights; Cancer Expert Now; HalioDx; Histosonics; Natera; omnihealth Media; QED Therapeutics
Speakers' Bureau - Bristol Myers Squibb; Merck; Natera; Seagen
(OPTIONAL) Uncompensated Relationships - Binacea
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; QED Therapeutics; Taiho Oncology
Speakers' Bureau - AstraZeneca
Research Funding - Taiho Pharmaceutical